Women and Coronary Artery Disease

Clinical Trial Finder

Many women with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Antiarrhythmics or Ablation for Ventricular Tachycardia Pilot

Condition:   Ventricular Tachycardia (VT)
Interventions:   Drug: Amiodarone or Sotalol;   Procedure: Catheter ablation
Sponsors:   John Sapp;   Heart and Stroke Foundation of Canada;   St. Jude Medical;   Biosense Webster, Inc.;   Ottawa Heart Institute Research Corporation
Not yet recruiting - verified July 2016

Tele-Health Electronic Monitoring to Reduce Post Discharge Complications and Surgical Site Infections

Condition:   Peripheral Vascular Disease
Intervention:   Other: Tele-Health Electronic Monitoring (THEM)
Sponsors:   CAMC Health System;   WVCTSI
Enrolling by invitation - verified July 2016

Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)

Conditions:   Hypertension;   Cardiovascular Disease
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified July 2016

Effects of Oral Sildenafil on Mortality in Adults With PAH

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: sildenafil citrate;   Drug: sildenafil citrate;   Drug: sildenafil citrate
Sponsor:   Pfizer
Recruiting - verified July 2016

Vest Prevention of Early Sudden Death Trial and VEST Registry

Conditions:   Myocardial Infarction;   Ventricular Dysfunction;   Sudden Death;   Ventricular Tachycardia;   Ventricular Fibrillation
Intervention:   Device: wearable defibrillator
Sponsors:   University of California, San Francisco;   Zoll Medical Corporation
Recruiting - verified July 2016

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Conditions:   Heart; Dysfunction Postoperative, Cardiac Surgery;   Genetic Predisposition to Disease;   Atrial Fibrillation;   Myocardial Infarction;   Heart Failure
Intervention:  
Sponsors:   Brigham and Women's Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   Texas Heart Institute;   University of Texas Southwestern Medical Center
Recruiting - verified July 2016

Effects of Amino Acids on Regional Lipid Metabolism

Condition:   Hypertriglyceridemia
Interventions:   Dietary Supplement: Amino acids;   Dietary Supplement: Placebo
Sponsors:   University of Arkansas;   National Institute on Aging (NIA)
Recruiting - verified July 2016

Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity

Condition:   Metabolic Syndrome X
Interventions:   Drug: Eplerenone;   Drug: Ramipril
Sponsor:   Vanderbilt University
Terminated - verified July 2016

Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.

Conditions:   Contraception;   Female Contraception;   Fertility Control
Intervention:  
Sponsors:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.;   Boston Collaborative Drug Surveillance Program
Completed - verified July 2016

Phenylephrine in Spinal Anesthesia in Preeclamptic Patients

Conditions:   Preeclampsia;   Hypotension
Interventions:   Drug: Ephedrine;   Drug: Phenylephrine
Sponsor:   Northwestern University
Recruiting - verified July 2016

A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control

Conditions:   Contraception;   Female Contraception
Interventions:   Drug: Transdermal Contraceptive System;   Drug: Norgestimate-containing oral contraceptives with EE
Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Completed - verified July 2016

Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia

Conditions:   Pulmonary Hypertension;   Sickle Cell Anemia;   Sickle Cell Disease
Intervention:  
Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified July 2016

Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia;   Postmenopause
Interventions:   Drug: estrogen replacement therapy;   Drug: hormone replacement therapy;   Drug: estradiol;   Drug: medroxyprogesterone
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2005

Women's Angiographic Vitamin and Estrogen Trial (WAVE)

Conditions:   Cardiovascular Diseases;   Coronary Arteriosclerosis;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia;   Postmenopause
Interventions:   Drug: estrogen replacement therapy;   Drug: estrogens, conjugated;   Drug: progesterone;   Drug: hormone replacement therapy;   Drug: supplementation, food;   Drug: ascorbic acid;   Drug: vitamin e
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2005